Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.9017
-0.0370 (-3.94%)
At close: Aug 26, 2026, 4:00 PM EDT
0.9200
+0.0183 (2.03%)
After-hours: Aug 26, 2026, 7:18 PM EDT
Invivyd Employees
Invivyd had 122 employees as of December 31, 2025. The number of employees increased by 22 or 22.00% compared to the previous year.
Employees
122
Change (1Y)
22
Growth (1Y)
22.00%
Revenue / Employee
$478,402
Profits / Employee
-$879,779
Market Cap
265.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 122 | 22 | 22.00% | 122 | 0 |
| Dec 31, 2024 | 100 | 5 | 5.26% | 99 | 1 |
| Dec 31, 2023 | 95 | 9 | 10.47% | 94 | 1 |
| Dec 31, 2022 | 86 | -17 | -16.50% | 84 | 2 |
| Dec 31, 2021 | 103 | - | - | 101 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Entrada Therapeutics | 152 |
| AC Immune | 122 |
| Lineage Cell Therapeutics | 77 |
| Neumora Therapeutics | 63 |
| ALX Oncology Holdings | 48 |
| Camp4 Therapeutics | 48 |
| Surrozen | 44 |
| Anavex Life Sciences | 34 |
IVVD News
- 13 days ago - Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 13 days ago - Invivyd Earnings release: Q2 2026 - Filings
- 13 days ago - Invivyd Quarterly report: Q2 2026 - Filings
- 22 days ago - Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Invivyd announces notice of termination for Pemgarda Emergency Use Authorization - TheFly
- 7 weeks ago - Invivyd Announces Receipt of Twelve Months' Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA - GlobeNewsWire
- 7 weeks ago - Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer - GlobeNewsWire